Hudson Heights Innovations Funding Opportunity

Columbia Technology Ventures is excited to announce the first call for proposals for Columbia’s newly launched therapeutics development collaboration with Deerfield Management, called Hudson Heights Innovations (HHI). Through HHI, Deerfield has allocated up to $130 million over 10 years in funding to support the translation of research into clinical therapeutics.


HHI is seeking proposals aimed at developing novel therapeutics from all therapeutic areas and modalities. Deerfield will provide funding and operational support for accepted proposals, and successful projects that achieve IND-enabled status may be eligible for additional capital as a startup funded by Deerfield. 


To apply, or to check whether your project would be eligible, please speak with your CTV Licensing Officer first, then visit to complete and submit the Letter-of-Intent (LOI). If you do not have a CTV Licensing Officer, please email to be assigned one. The deadline to submit LOIs is Thursday, April 9th.